Study questions best timing for powerful UC drug

This study looked back at medical records to see if using the drug upadacitinib as the first treatment for a severe flare of ulcerative colitis works better than using it as a 'rescue' therapy after other treatments fail. Researchers compared 81 patients to see which group had better outcomes, like avoiding surgery and achieving remission, and which group had fewer side effects. The goal was to understand the real-world effectiveness and safety of these two different treatment approaches.